IXCHIQ Chikungunya vaccine: temporary suspension in people aged 65 years or older

2026-02-11T15:01:50+00:00

The Commission on Human Medicines (CHM) has temporarily restricted use of the IXCHIQ Chikungunya vaccine in people aged 65 years and over following very rare fatal reactions reported globally. This is a precautionary measure while the MHRA conducts a safety review.…